| API Products :
|
|
Therapeutic
Category |
Product |
Tech
Pack / Open part |
EUDMF /
COS |
USDMF |
|
Antiallergic |
Cetirizine
2HCL |
√ |
|
|
|
Salbutamol
Sulphate |
√ |
|
|
|
Antibacterial |
Ciprofloxacin HCL |
√ |
R0-CEP
2008-176-Rev00 |
DMF No. 21909 |
|
Anticonvulsant |
Lamotrigine
|
√ |
|
|
|
Pregabalin |
√ |
* |
* |
|
Antidepressant |
Quetiapine
Fumarate |
√ |
* |
* |
|
Sertraline
HCL |
√ |
|
|
|
Antidiabetic |
Glibenclamide |
√ |
|
|
|
Gliclazide |
|
* |
|
|
Glimepiride |
√ |
Filed: CEP 2008-067 |
DMF No. 22565 |
|
Metformin
HCL
|
√ |
R0-CEP
2007-188-Rev01 |
DMF No. 21097 |
|
Metformin
HCL 90% / 95% DC |
√ |
|
|
|
Antifungal |
Itraconazole Pellets 20% / 22
% |
√ |
|
|
|
Fluconazole |
√ |
|
|
|
Antigout |
Allopurinol |
√ |
R0-CEP 2008-017-Rev
00 |
DMF No. 21239 |
|
|
Amlodipine
Besylate |
√ |
|
|
|
Carvedilol |
√ |
* |
* |
|
Enalapril
Maleate |
√ |
|
|
|
Losartan
Potassium |
√ |
|
|
|
Ramipril |
√ |
|
|
|
Antiparkinson |
Rasagiline
Mesylate |
√ |
* |
* |
|
Antiulcer
|
Esomeprazle
Pellets 8.5% / 22.5% |
√ |
|
|
|
Lansoprazole Pellets 8.0% /
8.5% |
√ |
|
|
|
Omeprazole
Pellets 7.5% / 8.5% |
√ |
|
|
|
Dermatology
|
Adapalene |
√ |
* |
* |
|
Tazarotene |
√ |
* |
* |
|
Lipid
lowering agent |
Ezetimibe
|
√ |
* |
* |
|
Ophthalmic |
Betaxolol
HCL |
√ |
* |
* |
|
Brimonidine
Tartrate |
√ |
EUDMF Available |
DMF No. 22166 |
|
Bromfenac
Sodium |
√ |
* |
* |
|
Brinzolamide |
√ |
* |
* |
|
Dorzolamide
HCL |
√ |
* |
* |
|
Nepafenac
Sodium |
√ |
* |
* |
|
Olopatadine
HCL |
√ |
* |
* |
|
Antispasmodic |
Dicyclomine
HCL |
√ |
R0-CEP 2008-281-Rev
00 |
DMF No. 22295 |
|
Muscle
relaxant |
Chlorzoxazone |
√ |
|
|
|
Vasodilator |
Cinnarizine |
√ |
|
|
|
VETERINARY |
|
Antibacterial
|
Ciprofloxacin HCL |
√ |
|
|
|
Enrofloxacin |
√ |
|
|
|
Antihelminthic |
Diminazene
Di Aceturate |
√ |
|
|
|
Niclosamide |
√ |
|
|
|
Oxyclozanide |
√ |
|
|
|
Rafoxanide |
√ |
|
|
|
Triclabendazole |
√ |
|
|
|
Antiprotozoal |
Ethopabate |
√ |
|
|
|
* Under preparation for filing
Disclaimer: The above products are under development or study
for internal or experimental uses and this list has no commercial
purpose. None of the products mentioned above are offered for sale
or supplied yet. The products & their intermediates will not be
sold in countries, in which they are protected by valid patents.
|
|
|
|
